{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:24:52Z","timestamp":1792193092323,"version":"4.4.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1097\/md.0000000000005916","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T21:05:45Z","timestamp":1495573545000},"page":"e5916","source":"Crossref","is-referenced-by-count":16,"title":["Impact of betablockers on general and local outcome in patients hospitalized for lower extremity peripheral artery disease"],"prefix":"10.1097","volume":"96","author":[{"given":"Tristan","family":"Mirault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Galloula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Cambou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Aboyans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Boulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Constans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bura-Riviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Messas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210226","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA"},{"key":"R2-22-20210226","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"R3-22-20210226","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"R4-22-20210226","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"key":"R5-22-20210226","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"R6-22-20210226","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"R7-22-20210226","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jvs.2014.03.290","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population","volume":"60","author":"Nehler","year":"2014","journal-title":"J Vasc Surg"},{"key":"R8-22-20210226","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2261-5-14","article-title":"The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database","volume":"5","author":"Caro","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"R9-22-20210226","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N Engl J Med"},{"key":"R10-22-20210226","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"R11-22-20210226","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","article-title":"Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia","volume":"63","author":"Westin","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R12-22-20210226","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jvs.2009.08.073","article-title":"Critical limb ischemia","volume":"51","author":"Varu","year":"2010","journal-title":"J Vasc Surg"},{"key":"R13-22-20210226","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/archinte.164.4.440","article-title":"Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction","volume":"164","author":"Narins","year":"2004","journal-title":"Arch Intern Med"},{"key":"R14-22-20210226","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.1969.03160130055016","article-title":"Peripheral arterial insufficiency. A complication of beta-adrenergic blocking therapy","volume":"208","author":"Frohlich","year":"1969","journal-title":"JAMA"},{"key":"R15-22-20210226","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archinte.1991.00400090063012","article-title":"Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials","volume":"151","author":"Radack","year":"1991","journal-title":"Arch Intern Med"},{"key":"R16-22-20210226","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1248\/yakushi.124.825","article-title":"Beta-adrenergic blocking agents and intermittent claudication: systematic review","volume":"124","author":"Miyajima","year":"2004","journal-title":"Yakugaku Zasshi"},{"key":"R17-22-20210226","first-page":"CD005508","article-title":"Beta blockers for peripheral arterial disease","volume":"9","author":"Paravastu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-22-20210226","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ejvs.2010.02.009","article-title":"Characteristics and outcome of patients hospitalised for lower extremity peripheral artery disease in France: the COPART Registry","volume":"39","author":"Cambou","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R19-22-20210226","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/clpt.1985.3","article-title":"Chronic effects of labetalol, pindolol, and propranolol on calf blood flow in intermittent claudication","volume":"37","author":"Lep\u00e4ntalo","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"R20-22-20210226","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2125.1984.tb05027.x","article-title":"Chronic effects of metoprolol and methyldopa on calf blood flow in intermittent claudication","volume":"18","author":"Lep\u00e4ntalo","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"R21-22-20210226","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/bmj.303.6810.1100","article-title":"Beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination","volume":"303","author":"Solomon","year":"1991","journal-title":"BMJ"},{"key":"R22-22-20210226","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.CIR.72.6.1226","article-title":"Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease","volume":"72","author":"Hiatt","year":"1985","journal-title":"Circulation"},{"key":"R23-22-20210226","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.0954-6820.1986.tb03293.x","article-title":"The effects of acebutolol and metoprolol on walking distances and distal blood pressure in hypertensive patients with intermittent claudication","volume":"219","author":"Svendsen","year":"1986","journal-title":"Acta Med Scand"},{"key":"R24-22-20210226","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/cpt1975175612","article-title":"Controlled trial of propranolol in intermittent claudication","volume":"17","author":"Reichert","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"R25-22-20210226","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(87)92441-X","article-title":"Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication","volume":"2","author":"Roberts","year":"1987","journal-title":"Lancet"},{"key":"R26-22-20210226","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.eurheartj.a061440","article-title":"Lack of influence of propranolol and metoprolol on walking distance in patients with chronic intermittent claudication","volume":"4","author":"Bogaert","year":"1983","journal-title":"Eur Heart J"},{"key":"R27-22-20210226","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/HJH.0b013e3283471151","article-title":"Effect of nebivolol vs. hydrochlorothiazide on the walking capacity in hypertensive patients with intermittent claudication","volume":"29","author":"Diehm","year":"2011","journal-title":"J Hypertens"},{"key":"R28-22-20210226","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/HYPERTENSIONAHA.110.169169","article-title":"\u03b2-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial","volume":"58","author":"Espinola-Klein","year":"2011","journal-title":"Hypertension"},{"key":"R29-22-20210226","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"R30-22-20210226","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"R31-22-20210226","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"R32-22-20210226","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart Failure Survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 2: Treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"key":"R33-22-20210226","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1053\/euhj.2002.3193","article-title":"A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)","volume":"23","author":"Hasdai","year":"2002","journal-title":"Eur Heart J"},{"key":"R34-22-20210226","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/jama.1997.03540260029031","article-title":"Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction","volume":"277","author":"Soumerai","year":"1997","journal-title":"JAMA"},{"key":"R35-22-20210226","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejvs.2013.04.006","article-title":"Beta-blocker use and clinical outcomes after primary vascular surgery: a nationwide propensity score-matched study","volume":"46","author":"H\u00f8gh","year":"2013","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R36-22-20210226","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jvs.2006.04.002","article-title":"Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study","volume":"44","author":"Blacher","year":"2006","journal-title":"J Vasc Surg"},{"key":"R37-22-20210226","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"R38-22-20210226","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/eurheartj\/ehl092","article-title":"Association of low ankle brachial index with high mortality in primary care","volume":"27","author":"Diehm","year":"2006","journal-title":"Eur Heart J"},{"key":"R39-22-20210226","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2458-10-38","article-title":"The peripheral arterial disease study (PERART\/ARTPER): prevalence and risk factors in the general population","volume":"10","author":"Alzamora","year":"2010","journal-title":"BMC Public Health"},{"key":"R40-22-20210226","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0950-821X(05)80676-0","article-title":"The fate of the claudicant\u2014a prospective study of 1969 claudicants","volume":"5","author":"Dormandy","year":"1991","journal-title":"Eur J Vasc Surg"},{"key":"R41-22-20210226","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/hc0702.104126","article-title":"Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein","volume":"105","author":"Rossi","year":"2002","journal-title":"Circulation"},{"key":"R42-22-20210226","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5114\/aoms.2012.28568","article-title":"Peripheral arterial disease of the lower extremities","volume":"8","author":"Aronow","year":"2012","journal-title":"Arch Med Sci"},{"key":"R43-22-20210226","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jvs.2013.04.007","article-title":"Chronic kidney disease and the short-term risk of mortality and amputation in patients hospitalized for peripheral artery disease","volume":"58","author":"Lacroix","year":"2013","journal-title":"J Vasc Surg"},{"key":"R44-22-20210226","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejvs.2014.04.005","article-title":"Anemia, an independent predictive factor for amputation and mortality in patients hospitalized for peripheral artery disease","volume":"48","author":"Desormais","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:42:11Z","timestamp":1620960131000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201702030-00022"}},"subtitle":["The COPART Registry"],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005916","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}